KIRKLAND, Wash.--(BUSINESS WIRE)--Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral arterial disease (PAD), today introduced the 7 French compatible version of its peripheral atherectomy catheter. Jetstream G2™ NXT is based on the company’s state-of-the-art catheter technology capable of treating the entire spectrum of disease found in patients suffering from PAD, including hard and soft plaque, calcium, fibrotic lesions and thrombus. 7 French compatibility allows physicians to use Jetstream G2 NXT in the treatment of PAD in a more diverse patient population, significantly expanding the number of patients who can now benefit from this innovative technology.
